SALESFORCE INC (CRM)       160.25  +8.57 (+5.65%)

160.25  +8.57 (+5.65%)

US79466L3024 - Common Stock - After market: 149.1 -11.15 (-6.96%)


Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to CRM. CRM was compared to 369 industry peers in the Software industry. Both the profitability and the financial health of CRM get a neutral evaluation. Nothing too spectacular is happening here. CRM is quite expensive at the moment. It does show a decent growth rate.




Profitability

Profitability Rating

4

CRM's Return On Assets of 0.57% is amongst the best of the industry. CRM does better than the industry average Return On Assets of -11.76%.
CRM has a Profit Margin of 1.83%. This is better than the industry average of -22.20%.

The Piotroski-F score of CRM is 6.00. This is a neutral score and indicates average health and profitability for CRM.
CRM has a Return On Equity of 0.89%. This is below the industry average of 11.69%. 95% of the industry peers outperform CRM.
VS Industry

ROA (0.57%) VS Industry: 75% outperformed.

-1,731.36
102.42

ROE (0.89%) VS Industry: 5% outperformed.

0.28
278.50

Profit Margin (1.83%) VS Industry: 74% outperformed.

-120,709.80
941.10

Valuation

Valuation Rating

3

Compared to an average industry Price/Earning Ratio of 32.86, CRM is valued in line with its industry peers.
CRM's PEG Ratio, which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
When comparing the current price to the book value of CRM, we can conclude it is valued correctly. It is trading at 2.67 times its book value.
Compared to an average industry price book ratio of 2.84, CRM is valued in line with its industry peers.

With a Price/Earnings Ratio of 37.44, CRM can be considered very expensive at the moment.
With a Forward Price/Earnings Ratio of 27.94, CRM is valued very expensively.
Compared to an average industry Enterprise Value to EBITDA ratio of 15.59, CRM is valued more expensive than its industry peers.
VS Industry

Price/Earnings (37.44) VS Industry: 44% outperformed.

4,014.00
0.38

Price/Book (2.67) VS Industry: 52% outperformed.

287.27
0.10

Enterprise Value/ EBITDA (37.58) VS Industry: 22% outperformed.

1,266.93
0.06

Growth

Growth Rating

6

Measured over the past 5 years, CRM shows a very strong growth in Earnings Per Share. The EPS has been growing by 36.85% on average per year.
The Earnings Per Share is expected to grow by 16.69% on average over the next 5 years. This is quite good.
Looking at the last year, CRM shows a very strong growth in Revenue. The Revenue has grown by 24.56%.
Measured over the past 5 years, CRM shows a very strong growth in Revenue. The Revenue has been growing by 25.71% on average per year.

Based on estimates for the next 5 years, CRM will show a quite strong growth in Revenue. The Revenue will grow by 12.98% on average per year.
CRM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -21.76%.
The EPS growth is decreasing: in the next 5 years the growth will be less than in the last years.
The Revenue growth is decreasing: in the next 5 years the growth will be less than in the last years.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS36.85% 22.99% -21.76% -0.28% 9.31% 13.86% 16.69%
Revenue25.71% 25.88% 24.56% 17.39% 16.03% 16.25% 12.98%

Health

Health Rating

4

An Altman-Z score of 3.11 indicates that CRM is not in any danger for bankruptcy at the moment.
CRM is in better financial health than average in its industry. Its Altman-Z score is much better than the industry average of 1.70.
A Current Ratio of 1.06 indicates that CRM should not have too much problems paying its short term obligations.
CRM has a Quick Ratio of 1.06. This is a normal value and indicates that CRM is financially healthy and should not expect problems in meeting its short term obligations.

CRM has a Piotroski-F score of 6.00. This indicates an average health and profitability for CRM.
Compared to an average industry Current Ratio of 1.82, CRM is worse placed to pay its short term obligations than its industry peers.
Compared to an average industry Quick Ratio of 1.80, CRM is worse placed to pay its short term obligations than its industry peers.
Compared to an average industry Debt to Equity Ratio of 0.04, CRM is more dependent on financing than its industry peers.
VS Industry

Debt/Equity (0.16) VS Industry: 38% outperformed.

51.02
0.00

Quick Ratio (1.06) VS Industry: 25% outperformed.

0.03
83.89

Current Ratio (1.06) VS Industry: 23% outperformed.

0.03
83.89

Altman-Z (3.11) VS Industry: 64% outperformed.

-182.70
250.30

Dividend

Dividend Rating

0

No dividends for CRM!.

CRM Daily chart

SALESFORCE INC160.25

NYSE:CRM (11/30/2022, 5:40:29 PM)+8.57 (+5.65%)

After market: 149.1 -11.15 (-6.96%)

Chartmill FA Rating
GICS Sector Information Technology
GICS IndustryGroup Software & Services
GICS Industry Software
Earnings (Last) 08-24 2022-08-24/amc Earnings (Next) 11-30 2022-11-30/amc
Ins Owners 2.91% Inst Owners 77.25%
Market Cap 160.25B Analysts 81.85
Valuation
PE 37.44 Fwd PE 27.94
PEG (NY) N/A PEG (5Y) 1.02
P/S 5.47 P/B 2.67
EV/EBITDA 37.58
Dividend
Dividend Yield N/A Dividend Growth N/A
DP N/A Ex-Date N/A
Growth
EPS 1Y -21.76% EPS 3Y 22.99%
EPS 5Y 36.85% EPS growth Q2Q -19.59%
EPS Next Y -0.28% EPS Next 2Y 9.31%
EPS Next 3Y 13.86% EPS Next 5Y 16.69%
Revenue growth 1Y 24.56% Revenue growth 3Y 25.88%
Revenue growth 5Y 25.71% Revenue growth Q2Q 21.77%
Revenue Next Year 17.39% Revenue Next 2Y 16.03%
Revenue Next 3Y 16.25% Revenue Next 5Y 12.98%
Health
Current Ratio 1.06 Quick Ratio 1.06
Altman-Z 3.11 F-Score 6
Debt/Equity 0.16 WACC 10.67%
ROIC/WACC 0.17
Profitability
ROA 0.57% ROE 0.89%
ROICexgc 1.81% ROIC 0.1%
PM 1.83% OM 0.26%
Asset Turnover 0.31

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA